| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |